Impact of 5-ASA discontinuation in children with ulcerative colitis on biologic therapy: A propensity score-matched study
{{output}}
Objectives: 5-Aminosalicylic acid (5-ASA) is recommended as a first-line medication in mild to moderate ulcerative colitis (UC), but indications regarding its use in children with moderate to severe disease treated with biologics... ...
